Mr Paul Brooke

KANDO id: 78949

Bio

Mr. Brooke has over 30 years of experience in life science analysis, investing, and management. Mr. Brooke was the Global Head of Health Care and Strategy for Morgan Stanley and headed up Morgan Stanley Japan. Currently a Senior Advisor to Morgan Stanley and a Director of ViroPharma, Incyte, and HLTH (WebMD), Paul plays an active role in managing the growth of many leading companies in the biotech sector. Through his role as CEO of Ithaka, he structured the purchase of Alsius Corp and successfully sold its assets to Zoll Medical in 2008. He was an advisor to MPM Capital and a Member of the Board of Directors of the MPM BioEquities Fund. Paul is a Managing Member of PMSV Holdings (an investment advisory firm), and a former Managing Director of Tiger Management. Graduated from M.A., Columbia University and A.B., Columbia University

Education